NCT00234000 2020-07-31Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesJonsson Comprehensive Cancer CenterPhase 1 Terminated1 enrolled
NCT00997243 2017-05-10Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic SyndromesOhio State University Comprehensive Cancer CenterPhase 2 Terminated7 enrolled 8 charts